Translate
Black Diamond Therapeutics, Inc.
About
Black Diamond Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Apr 21 2026
Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting
Mar 16 2026
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Jan 28 2026
Convergent Therapeutics Appoints Elizabeth L. Montgomery Chief People Officer
Dec 3 2025
Black Diamond Therapeutics Announces Preliminary Phase 2 Data for Silevertinib in 1L NSCLC and Plans for a Phase 2 Trial of Silevertinib in GBM